Canine Pancreatic Lipase (cPLI) in the Diagnosis and Testing of Canine Pancreatitis

With the rapid development of veterinary medicine, diagnostic and therapeutic methods for canine diseases have become increasingly sophisticated. Canine pancreatitis, as a common gastrointestinal disease, is a key diagnostic and testing method, and Canine Pancreatic Lipase (cPLI), as a biomarker with high specificity, plays an important role in the diagnosis and testing of canine pancreatitis.

Importance of cPLI in the diagnosis of canine pancreatitis

Canine pancreatitis is a chemical inflammation of the pancreatic tissue due to auto-digestion caused by abnormal activation of pancreatic enzymes in the pancreas. The main symptoms of the disease include acute abdominal pain, loss of appetite, vomiting, diarrhoea and may sometimes be accompanied by bloody stools. Since these symptoms are not specific and may be confused with other diseases, an accurate diagnosis is essential.

Levels of cPLI, a pancreas-specific lipase, are significantly elevated in pancreatitis. Therefore, by testing cPLI levels in serum or plasma, it can assist the physician in making an accurate diagnosis of canine pancreatitis.

Canine pancreatic lipase Tests and Diagnostic Methods 

Laboratory Tests of CPL

Laboratory testing is the most commonly used method for detecting cPLI. This method collects blood samples from dogs, centrifuges them to separate the serum or plasma, and then uses a specific test kit to quantitatively detect cPLI levels. This method has the advantage of being highly accurate, but requires specialised laboratory equipment and personnel to operate.

Rapid diagnostic reagents of canine pancreatic lipase

In recent years, with the continuous development of pet medical technology, some rapid diagnostic reagents have been gradually applied in the diagnosis of canine pancreatitis. These reagents use immunochromatographic technology or enzyme-linked immunosorbent assay (ELISA), etc., and can quickly detect the cPLI level in blood samples in a short period of time. For example, the Sabervet cPL rapid test is a rapid diagnostic reagent based on the ELISA method, which can produce canine pancreatic lipase test results in less than 10 minutes and has high sensitivity and specificity.

Prospects for the application of cPLI testing and diagnosis

With the in-depth study of the pathogenesis of canine pancreatitis and the continuous progress of diagnostic technology, cPLI, as a biomarker with high specificity, plays an increasingly important role in the diagnosis and testing of canine pancreatitis. In the future, with the development of more efficient and convenient detection methods and reagents, we can expect that the diagnosis of canine pancreatitis will become more rapid, accurate and convenient.

Meanwhile, for pet owners, understanding and paying attention to their pets’ health status, timely detection and treatment of diseases are important measures to protect their pets’ health. Therefore, it is recommended that pet owners take their pets to the doctor in time when they find their pets with suspected symptoms of pancreatitis and cooperate with the doctor to carry out the necessary examinations and treatments.

In conclusion, Canine Pancreatic Lipase (cPLI), as a biomarker with high specificity, plays an important role in the diagnosis and testing of canine pancreatitis. Through methods such as laboratory assays or rapid diagnostic reagents, we can make an accurate and rapid diagnosis of canine pancreatitis for the health of our pets.

Antigenne, holding the banner of enjoying living together with animals and protecting the health both of animals and humans, is dedicated to building a harmonious society for humans and animals. Insisting on the values of innovation, honesty and integrity, sticking to the principle of “quality is the cornerstone of future existence, through innovative products and dimensional services, Antigenne is looking forward to cooperating with you and expecting to create a bright future with a win-win result.

With six years of industry experience, Antigenne has built a solid foundation of knowledge and expertise in developing efficiently and accurate diagnostic reagents. The creation of Itgen not only reinforces the company’s commitment to quality and innovation but also serves as a testament to its unwavering dedication to improving animal health and welfare. Together, we can make a difference. Contact Antigenne now and let’s unlock the future of animal health.